Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Clinical trial NCT00001705 · COMPLETED
Trial details
- NCT number
- NCT00001705
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-07-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.